Skip to content

Effects of body dysregulation after high-altitude descent on immunity and oxidative stress in hypertensive patients and intervention exploration

Effects of high-altitude de-acclimatization on immune and oxidative stress levels in hypertensive patients and intervention strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600131336
Enrollment
Unknown
Registered
2026-09-01
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Sponsors

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Patients with hypertension who meet the diagnostic criteria for primary hypertension, divided into the high-altitude group (residence altitude >= 2500 meters, continuous high-altitude residence time >= 1 year, recent relocation to a low-altitude area (altitude = 3 years, no high-altitude travel/residence history in the past 3 months). 2. Patients who voluntarily participate in this research project and are willing to continuously undergo monitoring of blood-related indicators and follow-up.

Exclusion criteria

Exclusion criteria: Exclusion criteria for diseases: 1. Secondary hypertension; patients with severe heart or lung failure; patients with severe liver dysfunction, defined as any time with a Child-Pugh liver disease severity grade of 2 or above; patients with severe kidney dysfunction, defined as any time with an estimated eGFR value of less than 30 ml/min and significant proteinuria; autoimmune diseases; patients with malignant tumors; various blood disorders; individuals in various acute or chronic inflammatory states; mental disorders requiring oral medication treatment. 2. Inconsistent altitude of residence, insufficient duration of residence in the plateau/flatland, or interruption of residence in the plateau/flatland due to various reasons such as tourism, work, or illness during the period of residence in the plateau/flatland.

Design outcomes

Primary

MeasureTime frame
T-cell subsets;

Secondary

MeasureTime frame
Interleukin-1 beta(IL-1ß);Serum ferritin (SF);Interleukin-6( IL-6 );Tumor necrosis factor-a(TNF-a );Interferon-gamma(IFN-?);Superoxide dismutase(SOD);Malondialdehyde(MDA);High-sensitivity C-reactive protein(hs-CRP);

Countries

China

Contacts

Public ContactJin Jing

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

675565641@qq.com+86 28 8739 7244

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026